GlassScriptPhysician profile
George G Gass
NPI 1710981196
$11,761.48
in general payments reported to CMS, 2019-2025
43 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,076 · 2020: $1,812 · 2021: $1,449 · 2022: $1,799 · 2023: $1,726 · 2024: $1,872 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,240 · Travel and Lodging: $1,369 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,239.89 |
| Travel and Lodging | $1,368.89 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,819.05 | 2020-2024 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,419.88 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,318.85 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Mylan Specialty L.P. | $1,131.38 | 2019-2024 | Yupelri |
| Pulmonx Corporation | $1,112.19 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $403.91 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.60 | 2019-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Gilead Sciences, INC. | $235.54 | 2019-2023 | |
| Galvanize Therapeutics, INC | $234.65 | 2023-2025 | Aliya System |
| Genzyme Corporation | $207.41 | 2022-2025 | |
| Insmed, INC. | $142.19 | 2025 | Brinsupri, Arikayce |
| Sunovion Pharmaceuticals INC. | $133.71 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $132.82 | 2019-2025 | Dupixent |
| Pfizer INC. | $120.28 | 2022-2025 | |
| Advanced Respiratory, INC | $82.52 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $80.67 | 2022-2025 | Smartvest |
| Viatris Specialty LLC | $79.88 | 2025 | Yupelri |
| Baxter Healthcare | $72.21 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $59.97 | 2024-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $59.95 | 2023-2024 | Acthar |
| Inogen, INC. | $58.87 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| United Therapeutics Corporation | $46.73 | 2023-2024 | Tyvaso |
| Philips North America LLC | $40.01 | 2019-2022 | |
| Csl Behring | $39.81 | 2019-2024 | Privigen, Hizentra |
| Takeda Pharmaceuticals U.S.A., INC. | $35.35 | 2023 | Glassia |
| Ani Pharmaceuticals, INC. | $28.68 | 2022 | |
| Jazz Pharmaceuticals INC. | $26.62 | 2024 | |
| Genentech USA, INC. | $26.49 | 2019-2021 | |
| Inspire Medical Systems, INC. | $23.86 | 2023 | Inspire |
| Shionogi INC | $22.02 | 2023 | Fetroja |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Verona Pharma, INC. | $20.15 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $17.62 | 2019 | |
| Hospira, INC. | $16.86 | 2024 | |
| Harmony Biosciences LLC | $16.39 | 2024 | |
| Cmp Pharma, INC. | $15.15 | 2023 | Tadliq |
| Abbvie INC. | $14.40 | 2024 | |
| Merck Sharp & Dohme LLC | $13.46 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.69 | 2020 | |
| Shire North American Group INC | $12.29 | 2019 | |
| Allergan, INC. | $12.14 | 2020 | |
| Circassia INC. | $10.82 | 2019 | |
| Body Vision Medical INC. | $7.19 | 2024 | Lungvision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Gass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.